Latest

Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆ Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆ Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications ◆

Updated 12 Aug 2026 · ClinicalTrials.gov

Clinical Trials in Hangzhou

← All China trials

Every active and recruiting clinical study with an investigative site in China — searchable by condition, sponsor, phase and location. Refreshed daily from the ClinicalTrials.gov registry.

8

Recruiting now

11

Active studies

Recruiting

AI-Optimized Single-Feature Recognition Model for Heart Failure

Cardiac Sound, Heart Failure - NYHA II - IV
Vivalink · started 2026-07-16

📍 Hangzhou

NCT07667452 on ClinicalTrials.gov ↗

Starting soon Phase 1/Phase 2

Phase I/II Clinical Study to Evaluate the Safety, Tolerability and Efficacy of LY-M003 Injection in Adult Patients With Wilson's Disease

Wilson's Disease
Lingyi Biotech Co., Ltd. · started 2026-06-15

📍 Hangzhou

NCT07641140 on ClinicalTrials.gov ↗

By invitation

Transcutaneous Auricular Vagus Nerve Stimulation for Preventing Acute Kidney Injury in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass

Acute Kidney Injury, Cardiac Surgery, Cardiopulmonary Bypass
Sir Run Run Shaw Hospital · started 2026-04-27

📍 Hangzhou

NCT07549243 on ClinicalTrials.gov ↗

Recruiting Phase 3

A Phase III Study of Deuremidevir Hydrobromide for the Treatment of RSV Infection in Infants and Young Children

Respiratory Syncytial Virus Infection
Simcere Pharmaceutical Co., Ltd · started 2026-03-11

📍 Xiamen · Changsha · Chengdu · Hangzhou

NCT07402512 on ClinicalTrials.gov ↗

Recruiting Phase 2

Safety and Efficacy of Tarperprumig in Adult Participants With Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Alexion Pharmaceuticals, Inc. · started 2025-11-26

📍 Baotou · Beijing · Guangzhou · Hangzhou · Nanchang · Shenzhen

NCT07160608 on ClinicalTrials.gov ↗

Recruiting Phase 2

A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse

Smoking
Eli Lilly and Company · started 2025-11-03

📍 Beijing · Chengdu · Chongqing · Hangzhou · Linhai · Ningbo

NCT07223840 on ClinicalTrials.gov ↗

Recruiting

Mechanistic Study on the Protective and Regenerative Effects of Spirulina in Hepatectomy-Related Liver Injury

Cholangiocarcinoma
Second Affiliated Hospital, Zhejiang University, School of Medicine · started 2025-10-01

📍 Hangzhou

NCT07263217 on ClinicalTrials.gov ↗

Recruiting

18F-mFBG PET Imaging in the Evaluation of Neuroblastoma

Neuroblastoma
First Affiliated Hospital of Zhejiang University · started 2025-02-04

📍 Hangzhou

NCT06852807 on ClinicalTrials.gov ↗

Recruiting Phase 2

Phase II Clinical Study of Befotertinib in EGFR Non-classical Mutant NSCLC

NSCLC (Non-small Cell Lung Cancer)
Second Affiliated Hospital, Zhejiang University, School of Medicine · started 2024-10-01

📍 Hangzhou

NCT06863506 on ClinicalTrials.gov ↗

Recruiting Phase 4

A Study for the Adjuvant Treatment of Breast Cancer

Breast Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine · started 2022-07-10

📍 Hangzhou

NCT05420467 on ClinicalTrials.gov ↗

Active Phase 2/Phase 3

A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

Relapsed/Refractory Diffuse Large B-cell Lymphoma
Karyopharm Therapeutics Inc · started 2020-09-03

📍 Nanjing · Suzhou · Huangpu · Xuhui · Chengdu · Hangzhou

NCT04442022 on ClinicalTrials.gov ↗

No trials match your search.

Browse by location

Beijing · 65 Guangzhou · 30 Shanghai · 28 Fuzhou · 14 Chengdu · 14 Changsha · 13 Shenzhen · 12 Hangzhou · 11 Tianjin · 10 Wuhan · 9 Chongqing · 8 Changchun · 7

Browse by condition

Breast Cancer · 5 Artificial Intelligence (AI) · 2 Healthy · 2 Aneurysmal Subarachnoid Hemorrhage · 2 Prostate Cancer · 2 Nasopharyngeal Cancinoma (NPC) · 2 Solid Tumors · 2 Healthy Participants · 2 Ischemic Stroke · 2 Wet Age-related Macular Degenerat… · 2 Plaque Psoriasis · 2 Solid Tumor · 2 Colorectal Cancer · 2 Gastric Cancer · 2 Lung Cancer (NSCLC) · 2 Pulmonary Function · 2

Cite this page

Priya Life Science (2026). Clinical Trials in China Tracker. Available at: https://priyalifescience.com/clinical-trials-china/city/hangzhou (Accessed: 12 August 2026).

Source: ClinicalTrials.gov, U.S. National Library of Medicine — studies listing at least one Chinese site, refreshed daily. Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician.